Tempest Therapeutics (TPST) PT Lowered to $5 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Edward Tenthoff lowered the price target on Tempest Therapeutics (NASDAQ: TPST) to $5.00 (from $8.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
